HIT Fund renews its support for Blue River Bio
The High Impact Technology Fund renewed its support for Blue River Bio's program in June 2026, awarding funding to advance the work it has backed since the company's earliest days.

In June 2026, the High Impact Technology (HIT) Fund renewed its support for Blue River Bio’s program and awarded funding to advance the work.
HIT Fund renewals are competitive and reflect progress against the milestones set at the outset. Along with funding, awardees continue to work with experienced industry executive advisors and gain introductions to strategic partners and investors.

